Breaking News Instant updates and real-time market news.

GNC

GNC Holdings

$4.19

(0.00%)

, UA

Under Armour

$13.18

(0.00%)

09:15
02/13/18
02/13
09:15
02/13/18
09:15

On The Fly: Pre-market Movers

UP AFTER EARNINGS: GNC Holdings (GNC), up 38.7%... Under Armour (UA, UAA), up 9.3% and 11%, respectively... Blue Apron (APRN), up 7.5%. ALSO HIGHER: AmerisourceBergen (ABC), up 12.9% following a Wall Street Journal article reporting that Walgreens Boots Alliance (WBA) reached out several weeks ago discuss the possibility of buying the portion of Amerisource it doesn't already own. DOWN AFTER EARNINGS: PepsiCo (PEP), down 1.1%... Charles River (CRL), up 1%. ALSO LOWER: Walgreens Boots Alliance is down 1.3% following the Wall Street Journal article about talks with AmerisourceBergen.

GNC

GNC Holdings

$4.19

(0.00%)

UA

Under Armour

$13.18

(0.00%)

UAA

Under Armour

$14.23

(0.00%)

APRN

Blue Apron

$3.35

(0.00%)

ABC

AmerisourceBergen

$89.45

(0.00%)

WBA

Walgreens Boots Alliance

$68.46

(0.00%)

PEP

PepsiCo

$111.93

0.75 (0.67%)

CRL

Charles River

$101.99

(0.00%)

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 17

    Feb

  • 19

    Feb

  • 20

    Mar

GNC GNC Holdings
$4.19

(0.00%)

01/31/18
DBAB
01/31/18
NO CHANGE
DBAB
Amazon remains low-price leader in supplements, says Deutsche Bank
Deutsche Bank analyst Shane Higgins conducted an online pricing study comparing 80 identical third-party online vitamin and supplement products at GNC Holdings (GNC), Vitamin Shoppe (VSI), Amazon (AMZN) and Bodybuilding.com. The study found that Amazon "easily expanded" its price advantage against each of the other three retailers, Higgins tells investors in a research note. Among the specialty players, Vitamin Shoppe slightly improved its price advantage versus GNC, the analyst adds. He expects Amazon to keep pressure on the specialty players, particularly as its Prime membership grows.
02/15/17
MACQ
02/15/17
NO CHANGE
Target $20
MACQ
Outperform
GNC Holdings shares pricing in 'draconian' outcomes, says Macquarie
Macquarie analyst Bob Summers said GNC Holdings' Q4 and near-term results will prove challenging but management has made decisions that will significantly increase the company's long-term potential to succeed by simplifying pricing and having consistent in-store and online pricing. The analyst said these efforts will pressure margins, but shares are pricing in "draconian" outcomes with shares trading at just over 4x P/E. Summers expects free cash flow to remain positive, which could be further enhanced by cutting the dividend and notes there are no near-term debt maturities to create credit risk. The analyst said even a "slight bend" in same-store sales trends could produce a dramatic positive outcome and reiterates his Outperform rating and $20 price target on GNC Holdings.
01/18/18
BOFA
01/18/18
NO CHANGE
Target $2.5
BOFA
Underperform
GNC Holdings options remain limited, says BofA/Merrill
BofA/Merrill analyst Curtis Nagle reiterated his Underperform rating and $2.50 price target on GNC Holdings saying he is skeptical that a turnaround under the One GNC strategy will lead to sustainable profitable growth. Nagle said GNC is lapping substantial price cuts this year that will make comp and gross margin growth difficult, and believes the company will have difficulty refinancing its $1.1B term loan without doing so at stiff rate.
04/19/17
JPMS
04/19/17
NO CHANGE
Target $12
JPMS
Neutral
GNC Holdings price target raised to $12 from $10 at JPMorgan
JPMorgan analyst Christopher Horvers raised his price target for GNC Holdings to $12 saying yesterday's earnings and comp beat "take off the table the terminal value question that many investors were focused on." The question, however, is if the traffic is sustainable and whether GNC can turn the decline in average ticket up, Horvers tells investors in a post-earnings research note. The analyst keeps a Neutral rating on the shares.
UA Under Armour
$13.18

(0.00%)

01/16/18
01/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Neutral at Macquarie with analyst Laurent Vasilescu citing weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. 2. Verizon (VZ) downgraded to Neutral from Buy at MoffettNathanson. 3. Lockheed Martin (LMT) and Rockwell Collins (COL) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Spirit Airlines (SAVE) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi saying he believes Spirit will benefit this year from an improving demand and revenue environment, but that its higher revenue risk relative to potential competitive responses to its expected capacity growth is not fully reflected in the stock at current levels. 5. Finisar (FNSR) downgraded to Sell from Neutral at Goldman Sachs with analyst Doug Clark saying risks of oversupply and competition are heating up in the optical component landscape. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/18
01/16/18
DOWNGRADE
Target $8

Underperform
Under Armour downgraded to Underperform at Macquarie
As previously reported, Macquarie analyst Laurent Vasilescu downgraded Under Armour to Underperform from Neutral and cut its price target to $8 from $10. Vasilescu lowered his FY18 EBIT to $25M from $85M to reflect weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. The analyst expects the credit agreement will need to be amended and expects Under Armour will need a capital raise if gross margins and SG&A continue to deteriorate.
02/06/18
JEFF
02/06/18
NO CHANGE
Target $72
JEFF
Hold
Jefferies sees too much management turnover at lululemon
The level of management turnover at lululemon during "this critical juncture in the company's growth trajectory gives us some pause," Jefferies analyst Randal Konik tells investors in a research note following the resignation of CEO Laurent Potdevin. The analyst sees better opportunities elsewhere, namely in shares of Under Armour (UAA), given lululemon's "high" valuation high and "less plentiful" margin opportunity going forward. He maintains a Hold rating on lululemon with a $72 price target.
02/09/18
JEFF
02/09/18
NO CHANGE
JEFF
Buy
Under Armour discounting down dramatically in last three months, says Jefferies
Jefferies analyst Randal Konik says his firms' February webscrapes point to better traction at Under Armour (UAA) with discounts down in each of the last three months. The company's discounts decreased from 70% in November to 23% in February, down more than 30% year-over-year this month, Konik tells investors in a research note. Further, a survey of 200 footwear retailers shows the Under Armour HOVR Phantom is building momentum, the analyst adds. In addition, the survey shows Nike (NKE) is gaining back share from adidas (ADDYY) in running across the U.S. and Europe. In Basketball, Nike continues to dominate, while Under Armour's Curry 4 is resonating well with consumers, Konik writes. The analyst has a Buy rating on Under Armour and Hold rating on Nike.
UAA Under Armour
$14.23

(0.00%)

APRN Blue Apron
$3.35

(0.00%)

12/04/17
LEHM
12/04/17
UPGRADE
Target $4
LEHM
Equal Weight
Blue Apron upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Ross Sandler upgraded Blue Apron to Equal Weight and raised his price target for the shares to $4 from $3. The meal delivery service closed Friday up 24c to $3.23. With the stock down 15% since the last earnings report, the risk/reward appears more favorable, Sandler tells investors in a research note. He views the promotion of Brad Dickerson to CEO as a positive but admits Blue Apron's competitive environment "remains fierce" with HelloFresh taking market share.
02/02/18
02/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. VF Corp. (VFC) initiated with an Overweight at Barclays. 2. JinkoSolar (JKS) initiated with a Sell at Vertical Group. 3. Chimerix (CMRX) initiated with a Buy at H.C. Wainwright. 4. Voyager Therapeutics (VYGR) initiated with an Overweight at Morgan Stanley. 5. Blue Apron (APRN) initiated with a Buy at Gabelli. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/02/18
GABE
02/02/18
INITIATION
Target $6
GABE
Buy
Blue Apron initiated with a Buy at Gabelli
Gabelli analyst Matthew Trusz initiated Blue Apron with a Buy and $6 private market value. Trusz believes Blue Apron has turned the corner on will publicized operational issues at its Linden facility since the IPO. The analyst expects revenue to compound over 20% annually to $2.4B by 2022, at which point Blue Apron will be generating more than $150 million of free cash flow, a third of the company's current enterprise value.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
ABC AmerisourceBergen
$89.45

(0.00%)

02/12/18
COWN
02/12/18
NO CHANGE
COWN
Recent pullback in drug distributors a buying opportunity, says Cowen
Cowen analyst Charles Ryhee said the recent pullback in drug distributors is unwarranted given the space's improving underlying fundamentals. He said the core distribution business is seeing stable generic pricing for both buy-side and sell-side and he believes concerns regarding likely proposed Medicare Part B changes are overblown. Ryhee reiterated his Outperform rating on both McKesson (MCK) and AmerisourceBergen (ABC) shares.
02/13/18
WELS
02/13/18
NO CHANGE
WELS
AmerisourceBergen acquisition by Walgreens makes sense, says Wells Fargo
Commenting on The Wall Street Journal report saying Walgreens (WBA) has approached AmerisourceBergen (ABC) in a takeover attempt and the companies remain early in their discussions, Wells Fargo analyst Peter Costa tells investors he believes the acquisition makes sense given the already existing long-term partnership and limited ability to merge laterally. Further, the analyst believes a potential combination could help lower costs and wring out synergies in the U.S. drug distribution channel, and better position Walgreens in the face of increasing competitive threat from a possible Amazon (AMZN) entry. However, a merger might risk alienating AmerisourceBergen's retail pharmacy customers that compete with Walgreens' pharmacies, he contends.
02/13/18
JEFF
02/13/18
NO CHANGE
Target $93
JEFF
Buy
Walgreens deal for AmerisourceBergen would be 'headscratcher,' says Jefferies
Jefferies analyst Brian Tanquilut says that while Walgreens Boots Alliance (WBA) acquiring AmerisourceBergen (ABC) would be accretive to earnings, it would be a "headscratcher" for investors. The companies already have a joint venture that affords both the strategic value that combining would provide, Tanquilut tells investors in a research note after the Wall Street Journal reported that Walgreens approached AmerisourceBergen a few weeks ago. The analyst has a Buy rating on Walgreens with a $93 price target. He adds that the potential deal would allow Walgreens to further expand its U.S. business.
02/13/18
LEER
02/13/18
NO CHANGE
LEER
Walgreens may seek to acquire AmerisourceBergen sooner than expected, says Leerink
Leerink analyst David Larsen notes that The Wall Street Journal reported that Walgreens (WBA) has approached AmerisourceBergen (ABC) about a potential takeover. The analyst is surprised that talks of such a large transaction have surfaced so quickly following the Rite Aid (RAD) deal, but says he has always believed that Walgreens at some point would seek to acquire either Express Scripts (ESRX) or AmerisourceBergen. Given the broad-based speculation in the business press about this deal, it is possible shares of Express Scripts will trade off, Larsen contends.
WBA Walgreens Boots Alliance
$68.46

(0.00%)

01/24/18
LEER
01/24/18
NO CHANGE
LEER
Amazon's prescription drug market entry likely to be slow, says Leerink
Leerink analyst David Larsen believes there is a high likelihood that Amazon (AMZN) will enter the prescription drug market, but thinks it may take years for the company to become a meaningful and relevant entity in the channel. The analyst expects Amazon will start off small, and does not believe it will seek to do a big acquisition initially. Ultimately, Amazon may simply become another mail-order pharmacy that buys its product from AmerisourceBergen (ABC), he contends, adding that the massive Amazon related sell-off in CVS (CVS) and Walgreens Boots Alliance (WBA) in late 2017 view was over-done.
PEP PepsiCo
$111.93

0.75 (0.67%)

01/30/18
BERN
01/30/18
NO CHANGE
Target $124
BERN
Market Perform
Dr Pepper Snapple price target raised to $124 from $92 at Bernstein
Bernstein analyst Ali Dibadj raised his price target for Dr Pepper Snapple to $124 from $92 after the company and Keurig Green Mountain announced a definitive merger agreement to create public company Keurig Dr Pepper. While the analyst views this merger as good for Dr Pepper Snapple shareholders, there are unanswered questions about the prospects as a combined entity, with revenue synergies remaining unclear, synergy targets appearing stretched, and the Coca-Cola (KO)/PepsiCo (PEP) distribution partnership remaining a risk. Dibadj reiterates a Market Perform rating on Dr Pepper Snapple's shares.
01/29/18
01/29/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PepsiCo (PEP) initiated with a Hold at SunTrust. 2. Synlogic (SYBX) initiated with an Overweight at Piper Jaffray. 3. Centennial Resource Development (CDEV) initiated with a Buy at Guggenheim. 4. Zynerba (ZYNE) initiated with a Buy at Ladenburg. 5. Radius Health (RDUS) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/29/18
RHCO
01/29/18
INITIATION
Target $125
RHCO
Hold
PepsiCo initiated with a Hold at SunTrust
As reported earlier, SunTrust analyst William Chappell initiated PepsiCo (PEP) with a Hold rating and a price target of $125. Chappell contends that after 5 years of price and promotion with Coca-Cola (KO), the companies' next phase will likely see "price increases or at least less promotional activity" on some beverage items. The analyst also notes that the investor concerns about the snacking category are overblown, pointing some recovery in Q4, while the positive FX, emerging markets, and tax reform dynamics create more tailwinds.
01/29/18
RHCO
01/29/18
INITIATION
Target $125
RHCO
Hold
PepsiCo initiated with a Hold at SunTrust
SunTrust initiated PepsiCo with a Hold and $125 price target.
CRL Charles River
$101.99

(0.00%)

01/22/18
RHCO
01/22/18
DOWNGRADE
Target $111
RHCO
Hold
Charles River downgraded to Hold at SunTrust on valuation
As reported earlier, SunTrust analyst Sandy Draper downgraded Charles River to Hold from Buy and lowered his price target to $111 from $113 as part of his broader "CRO Universe 2018 preview" research note. Draper says that while the momentum of a strong CRO industry carries into 2018, the PE valuations are now ahead of the 2- and 5-year averages, and the year should be "largely contingent on underlying earnings generation rather than further multiple expansion". For Charles River, Draper says the valuation "no longer excites us", adding there are downside risks from "weaker demand from large pharma due to less outsourcing or consolidation" as well as cost inflation margin pressure.
01/22/18
RHCO
01/22/18
DOWNGRADE
RHCO
Hold
Charles River downgraded to Hold from Buy at SunTrust
01/18/18
EVER
01/18/18
INITIATION
Target $117
EVER
In Line
Charles River initiated with an In Line at Evercore ISI
Evercore ISI started Charles River with an In Line rating and $117 price target.
12/13/17
12/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Lowe's (LOW) initiated with a Buy at Guggenheim. 2. Aimmune (AIMT) initiated with an Overweight at Cantor Fitzgerald. 3. Westlake Chemical (WLK) reinstated with a Buy at Deutsche Bank. 4. Wabtec (WAB) initiated with an Outperform at Cowen. 5. Charles River (CRL) initiated with a Buy at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$347.49

-14.69 (-4.06%)

21:14
06/21/18
06/21
21:14
06/21/18
21:14
Periodicals
Tesla job cuts to concentrate on the solar facilities, Reuters says »

As part of the 9% staff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

ECOR

ElectroCore

$0.00

(0.00%)

21:08
06/21/18
06/21
21:08
06/21/18
21:08
Syndicate
ElectroCore 5.2M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

TELNY

Telenor

$0.00

(0.00%)

20:43
06/21/18
06/21
20:43
06/21/18
20:43
Upgrade
Telenor rating change at JPMorgan »

Telenor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$71.05

-1.77 (-2.43%)

20:25
06/21/18
06/21
20:25
06/21/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.28

-1.72 (-0.62%)

, SPX

S&P 500

$0.00

(0.00%)

20:07
06/21/18
06/21
20:07
06/21/18
20:07
Periodicals
Money market funds pull the most funds since 2011, Reuters says »

Investors pulled $51B in…

SPY

SPDR S&P 500 ETF Trust

$274.28

-1.72 (-0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANZBY

ANZ Banking

$0.00

(0.00%)

19:53
06/21/18
06/21
19:53
06/21/18
19:53
Hot Stocks
ANZ Bank doubles share buyback to AUD 3B »

ANZ announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$185.48

-1.06 (-0.57%)

, QCOM

Qualcomm

$58.76

-0.03 (-0.05%)

19:50
06/21/18
06/21
19:50
06/21/18
19:50
Periodicals
Apple challenges four patents held by Qualcomm at USPTO, Bloomberg says »

Apple (AAPL) filed…

AAPL

Apple

$185.48

-1.06 (-0.57%)

QCOM

Qualcomm

$58.76

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$15.01

-0.2 (-1.31%)

19:42
06/21/18
06/21
19:42
06/21/18
19:42
Periodicals
Federal judge rules in Credit Suisse favor in a $300M broker suit, Reuters says »

A San Francisco federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$26.45

-0.8 (-2.94%)

, FUJIY

Fujifilm

$0.00

(0.00%)

19:19
06/21/18
06/21
19:19
06/21/18
19:19
Periodicals
Xerox judge rejects Fuji request to end deal vote injunction, Bloomberg says »

Fujifilm Holdings (FUJIY)…

XRX

Xerox

$26.45

-0.8 (-2.94%)

FUJIY

Fujifilm

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

19:11
06/21/18
06/21
19:11
06/21/18
19:11
Hot Stocks
Airbus says no-deal Brexit would lead to 'severe disruption' of U.K. production »

Airbus said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

, MDT

Medtronic

$86.29

0.11 (0.13%)

19:00
06/21/18
06/21
19:00
06/21/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Tandem Diabetes…

TNDM

TNDM

MDT

Medtronic

$86.29

0.11 (0.13%)

RHT

Red Hat

$165.62

-3.64 (-2.15%)

VMW

VMware

$152.08

-0.07 (-0.05%)

SPLK

Splunk

$113.06

-2.8 (-2.42%)

SGH

Smart Global

$39.79

-0.72 (-1.78%)

TCS

Container Store

$8.73

0.08 (0.92%)

LRCX

Lam Research

$176.01

1.54 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 07

    Jul

  • 09

    Jul

  • 10

    Jul

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

  • 12

    Jul

  • 12

    Jul

BDRBF

Bombardier

$0.00

(0.00%)

, ERJ

Embraer

$25.48

-0.2 (-0.78%)

18:53
06/21/18
06/21
18:53
06/21/18
18:53
Periodicals
Bombardier sees CRJ 900 winning 'half or more' of market share, Reuters says »

Bombardier's (BDRBF)…

BDRBF

Bombardier

$0.00

(0.00%)

ERJ

Embraer

$25.48

-0.2 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 02

    Aug

WOW

WideOpenWest

$9.44

-0.2497 (-2.58%)

18:37
06/21/18
06/21
18:37
06/21/18
18:37
Initiation
WideOpenWest initiated at B. Riley FBR »

WideOpenWest initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CABO

Cable One

$716.20

-2.81 (-0.39%)

18:37
06/21/18
06/21
18:37
06/21/18
18:37
Initiation
Cable One initiated at B. Riley FBR »

Cable One initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

, DIS

Disney

$105.89

-1.39 (-1.30%)

18:32
06/21/18
06/21
18:32
06/21/18
18:32
Hot Stocks
Disney offers to divest Fox assets generating up to $1B in EBITDA »

In a regulatory filing,…

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

DIS

Disney

$105.89

-1.39 (-1.30%)

CMCSA

Comcast

$32.80

-0.595 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$86.29

0.11 (0.13%)

18:29
06/21/18
06/21
18:29
06/21/18
18:29
Hot Stocks
Medtronic announces FDA approval of MiniMed 670G system »

Medtronic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

AEO

American Eagle

$25.27

0.615 (2.49%)

18:23
06/21/18
06/21
18:23
06/21/18
18:23
Hot Stocks
American Eagle director Page sells 44,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,157.63

-11.75 (-1.00%)

, GOOGL

Alphabet Class A

$1,169.56

-14.27 (-1.21%)

18:19
06/21/18
06/21
18:19
06/21/18
18:19
Periodicals
YouTube to let content creators sell monthly subscriptions, Bloomberg says »

Google's YouTube is…

GOOG

Alphabet

$1,157.63

-11.75 (-1.00%)

GOOGL

Alphabet Class A

$1,169.56

-14.27 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

NMR

Nomura

$4.85

-0.075 (-1.52%)

18:09
06/21/18
06/21
18:09
06/21/18
18:09
Periodicals
Nomura to cut 40 global markets traders in the U.S., Bloomberg says »

Nomura is expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$120.06

-0.2 (-0.17%)

18:02
06/21/18
06/21
18:02
06/21/18
18:02
Hot Stocks
SPDR Gold Trust holdings fall to 824.63MT from 828.76MT »

This is the first decline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.37

-0.13 (-0.24%)

17:50
06/21/18
06/21
17:50
06/21/18
17:50
Periodicals
Wells Fargo said to let go of 10 analysts to cut costs, Bloomberg reports »

Wells Fargo has laid off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

, DIS

Disney

$105.89

-1.39 (-1.30%)

17:47
06/21/18
06/21
17:47
06/21/18
17:47
Periodicals
Breaking Periodicals news story on 21st Century Fox, Disney, Comcast »

Disney to double asset…

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

DIS

Disney

$105.89

-1.39 (-1.30%)

CMCSA

Comcast

$32.80

-0.595 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

$118.81

3.54 (3.07%)

17:45
06/21/18
06/21
17:45
06/21/18
17:45
Conference/Events
Enanta management to meet with Oppenheimer »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

TNTR

Tintri

$0.20

0.0369 (22.38%)

17:32
06/21/18
06/21
17:32
06/21/18
17:32
Hot Stocks
Tintri receives Nasdaq noncompliance notice from 10-Q filing delay »

Tintri received a notice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUE

Cue Biopharma

$12.41

0.18 (1.47%)

17:25
06/21/18
06/21
17:25
06/21/18
17:25
Syndicate
Breaking Syndicate news story on Cue Biopharma »

Cue Biopharma files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.